A recent study by Sato et al. using stable isotope labelling method (SILK) to investigate tau metabolism suggests that the raised t-tau and p-tau levels seen in AD could be due to active production and secretion from neurons in response to Aβ pathology rather than a direct reflection of a neurodegenerative process [30]. The gene discussed is MAPT; the disease is Alzheimer disease.